ArticleJACC. Case reports2026
Arrhythmogenic Cardiomyopathy Diagnosed Late in a Master Recreational Endurance Athlete.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrompt recognition of arrhythmogenic conditions in recreational and competitive athletes is essential for clinical management and for providing appropriate exercise recommendations. CASE SUMMARY: We report the case of a 67-year-old athletic individual with a high burden of ventricular arrhythmias and a phenotype within the dilated/nondilated left ventricular cardiomyopathy spectrum. Genetic testing identified a likely causative variant in the Filamin C (FLNC) gene. An integrative evaluation incorporating advanced cardiac imaging, genetic analysis, and invasive electrophysiology was undertaken to optimize risk stratification and customize exercise counseling. DISCUSSION: In arrhythmogenic cardiomyopathy with confirmed or suspected genetic etiology, a multimodal evaluation is essential for accurate patient phenotyping. The impact of exercise on disease expression in specific gene variants associated with predominantly left-sided involvement remains insufficiently understood and requires further research and shared decision-making. TAKE-HOME MESSAGE: A comprehensive multidisciplinary evaluation is key for diagnosis, risk stratification, and management of athletes with ventricular arrhythmias.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.